Postes actifs de Mark Truesdale
Sociétés | Poste | Début | Fin |
---|---|---|---|
Solentim Ltd.
Solentim Ltd. BiotechnologyHealth Technology Part of Advanced Instruments LLC, Solentim Ltd. is a British company that specializes in workflows for antibody and cell-based therapies. The company is based in Wimborne, UK. The company's technologies enable the isolation, growth, and characterization of high-value cells, while their data-driven platform enables smarter decisions earlier in the process. The CEO of the company is Mark Truesdale. Solentim was acquired by Advanced Instruments LLC on September 30, 2021 for $333.83 million. | Directeur/Membre du Conseil | - | - |
Directeur Général | - | - |
Historique de carrière de Mark Truesdale
Statistiques
Internationale
Royaume-Uni | 2 |
Opérationnelle
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Sectorielle
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Solentim Ltd.
Solentim Ltd. BiotechnologyHealth Technology Part of Advanced Instruments LLC, Solentim Ltd. is a British company that specializes in workflows for antibody and cell-based therapies. The company is based in Wimborne, UK. The company's technologies enable the isolation, growth, and characterization of high-value cells, while their data-driven platform enables smarter decisions earlier in the process. The CEO of the company is Mark Truesdale. Solentim was acquired by Advanced Instruments LLC on September 30, 2021 for $333.83 million. | Health Technology |
- Bourse
- Insiders
- Mark Truesdale
- Expérience